Invaryant Revenue and Competitors
Estimated Revenue & Valuation
- Invaryant's estimated annual revenue is currently $2.3M per year.
- Invaryant's estimated revenue per employee is $101,500
Employee Data
- Invaryant has 23 Employees.
- Invaryant grew their employee count by 130% last year.
Invaryant's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Director Regulatory Affairs | Reveal Email/Phone |
3 | Account Manager | Reveal Email/Phone |
4 | Software Tester | Reveal Email/Phone |
5 | Integrated Cognitive AI | Reveal Email/Phone |
Invaryant Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $14.2M | 98 | -35% | N/A | N/A |
#2 | $42.1M | 264 | -27% | N/A | N/A |
#3 | $0.1M | 6 | 0% | $57.7M | N/A |
#4 | $73.6M | 406 | 5% | N/A | N/A |
#5 | $32.7M | 210 | 6% | $6.3M | N/A |
#6 | $7.7M | 61 | -14% | $29.5M | N/A |
#7 | $5.5M | 50 | 0% | $42.5M | N/A |
#8 | $31.9M | 200 | -3% | N/A | N/A |
#9 | $12M | 83 | 41% | N/A | N/A |
#10 | $15.8M | 109 | 21% | N/A | N/A |
What Is Invaryant?
Invaryant is a Georgia-based health tech company enabling safer healthcare through integrated, real-world data and patent-pending technologies. Our platform connects patients with those who make healthy possible, creating a secure, real-time, inter- & intraoperable environment for patient safety. Who benefits from Invaryant? • Patients • Physicians and other providers (in-person and telehealth) • Researchers • Patient safety programs (such as REMS and pharmacovigilance) To learn more or for a demonstration, visit invaryant.com or contact us at [email protected]
keywords:N/AN/A
Total Funding
23
Number of Employees
$2.3M
Revenue (est)
130%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.3M | 23 | -32% | N/A |
#2 | $2.3M | 23 | 0% | N/A |
#3 | $1.7M | 23 | 0% | N/A |
#4 | $2.4M | 24 | 20% | N/A |
#5 | $2.4M | 24 | -14% | N/A |